Krilogy Financial »

Candel Therapeutics shares owned by Krilogy Financial

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Krilogy Financial from 13F filings

Historical chart of Krilogy Financial investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Krilogy Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Krilogy Financial

Quarter filed Position value Share count Share price at filing
2025-12-31 $144k 24k 6.01

More positions owned by Krilogy Financial

Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Pimco Etf Tr Multisector Bd (PYLD)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Select Sector Spdr Tr State Street Tec (XLK)
Victory Portfolios Ii Shares Free Cash (VFLO)
Apple (AAPL)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Ishares Tr Ibonds Dec 2032 (IBTM)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
NVIDIA Corporation (NVDA)
Ishares Tr Rus Md Cp Gr Etf (IWP)
Amazon (AMZN)

View all positions for Krilogy Financial

Top funds holding Candel Therapeutics

FMR
BlackRock
Acorn Capital Advisors
Vanguard Group
Portolan Capital Management
Geode Capital Management
State Street Corporation
Halter Ferguson Financial
Citadel Advisors
Sands Capital Ventures
Northern Trust
Susquehanna International
Tanager Wealth Management
Jane Street
Wellington Management Company

View all funds holding Candel Therapeutics